These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 18625734)

  • 1. Outer membrane antigens of the uropathogen Proteus mirabilis recognized by the humoral response during experimental murine urinary tract infection.
    Nielubowicz GR; Smith SN; Mobley HL
    Infect Immun; 2008 Sep; 76(9):4222-31. PubMed ID: 18625734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uropathogenic Escherichia coli outer membrane antigens expressed during urinary tract infection.
    Hagan EC; Mobley HL
    Infect Immun; 2007 Aug; 75(8):3941-9. PubMed ID: 17517861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The type III secretion system of Proteus mirabilis HI4320 does not contribute to virulence in the mouse model of ascending urinary tract infection.
    Pearson MM; Mobley HLT
    J Med Microbiol; 2007 Oct; 56(Pt 10):1277-1283. PubMed ID: 17893161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zinc uptake contributes to motility and provides a competitive advantage to Proteus mirabilis during experimental urinary tract infection.
    Nielubowicz GR; Smith SN; Mobley HL
    Infect Immun; 2010 Jun; 78(6):2823-33. PubMed ID: 20385754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of virulence determinants in uropathogenic Proteus mirabilis using signature-tagged mutagenesis.
    Himpsl SD; Lockatell CV; Hebel JR; Johnson DE; Mobley HLT
    J Med Microbiol; 2008 Sep; 57(Pt 9):1068-1078. PubMed ID: 18719175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteus mirabilis genes that contribute to pathogenesis of urinary tract infection: identification of 25 signature-tagged mutants attenuated at least 100-fold.
    Burall LS; Harro JM; Li X; Lockatell CV; Himpsl SD; Hebel JR; Johnson DE; Mobley HL
    Infect Immun; 2004 May; 72(5):2922-38. PubMed ID: 15102805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete genome sequence of uropathogenic Proteus mirabilis, a master of both adherence and motility.
    Pearson MM; Sebaihia M; Churcher C; Quail MA; Seshasayee AS; Luscombe NM; Abdellah Z; Arrosmith C; Atkin B; Chillingworth T; Hauser H; Jagels K; Moule S; Mungall K; Norbertczak H; Rabbinowitsch E; Walker D; Whithead S; Thomson NR; Rather PN; Parkhill J; Mobley HL
    J Bacteriol; 2008 Jun; 190(11):4027-37. PubMed ID: 18375554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-wide transposon mutagenesis of Proteus mirabilis: Essential genes, fitness factors for catheter-associated urinary tract infection, and the impact of polymicrobial infection on fitness requirements.
    Armbruster CE; Forsyth-DeOrnellas V; Johnson AO; Smith SN; Zhao L; Wu W; Mobley HLT
    PLoS Pathog; 2017 Jun; 13(6):e1006434. PubMed ID: 28614382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The high-affinity phosphate transporter Pst is a virulence factor for Proteus mirabilis during complicated urinary tract infection.
    Jacobsen SM; Lane MC; Harro JM; Shirtliff ME; Mobley HL
    FEMS Immunol Med Microbiol; 2008 Mar; 52(2):180-93. PubMed ID: 18194341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of protease and rpoN-associated genes of uropathogenic Proteus mirabilis by negative selection in a mouse model of ascending urinary tract infection.
    Zhao H; Li X; Johnson DE; Mobley HLT
    Microbiology (Reading); 1999 Jan; 145 ( Pt 1)():185-195. PubMed ID: 10206698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Proteus mirabilis structural fimbrial proteins as antigens against urinary tract infections.
    Pellegrino R; Galvalisi U; Scavone P; Sosa V; Zunino P
    FEMS Immunol Med Microbiol; 2003 May; 36(1-2):103-10. PubMed ID: 12727373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptome of Proteus mirabilis in the murine urinary tract: virulence and nitrogen assimilation gene expression.
    Pearson MM; Yep A; Smith SN; Mobley HL
    Infect Immun; 2011 Jul; 79(7):2619-31. PubMed ID: 21505083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of green fluorescent protein to assess urease gene expression by uropathogenic Proteus mirabilis during experimental ascending urinary tract infection.
    Zhao H; Thompson RB; Lockatell V; Johnson DE; Mobley HL
    Infect Immun; 1998 Jan; 66(1):330-5. PubMed ID: 9423875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. UreR, the transcriptional activator of the Proteus mirabilis urease gene cluster, is required for urease activity and virulence in experimental urinary tract infections.
    Dattelbaum JD; Lockatell CV; Johnson DE; Mobley HL
    Infect Immun; 2003 Feb; 71(2):1026-30. PubMed ID: 12540589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction of a urease-negative mutant of Proteus mirabilis: analysis of virulence in a mouse model of ascending urinary tract infection.
    Jones BD; Lockatell CV; Johnson DE; Warren JW; Mobley HL
    Infect Immun; 1990 Apr; 58(4):1120-3. PubMed ID: 2180821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of polyphosphate kinase in virulence and stress tolerance of uropathogenic Proteus mirabilis.
    Peng L; Jiang Q; Pan JY; Deng C; Yu JY; Wu XM; Huang SH; Deng XY
    Med Microbiol Immunol; 2016 Apr; 205(2):97-109. PubMed ID: 26233310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Native flagellin does not protect mice against an experimental Proteus mirabilis ascending urinary tract infection and neutralizes the protective effect of MrpA fimbrial protein.
    Scavone P; Umpiérrez A; Rial A; Chabalgoity JA; Zunino P
    Antonie Van Leeuwenhoek; 2014 Jun; 105(6):1139-48. PubMed ID: 24771125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteus mirabilis flagella and MR/P fimbriae: isolation, purification, N-terminal analysis, and serum antibody response following experimental urinary tract infection.
    Bahrani FK; Johnson DE; Robbins D; Mobley HL
    Infect Immun; 1991 Oct; 59(10):3574-80. PubMed ID: 1680106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomic analysis of Proteus mirabilis outer membrane proteins reveals differential expression in vivo vs. in vitro conditions.
    D'Alessandro B; Lery LM; von Krüger WM; Lima A; Piccini C; Zunino P
    FEMS Immunol Med Microbiol; 2011 Nov; 63(2):174-82. PubMed ID: 22077220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of an intranasal vaccine to prevent urinary tract infection by Proteus mirabilis.
    Li X; Lockatell CV; Johnson DE; Lane MC; Warren JW; Mobley HL
    Infect Immun; 2004 Jan; 72(1):66-75. PubMed ID: 14688082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.